formaldehyde has been researched along with Lesion of Sciatic Nerve in 9 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Excerpt | Relevance | Reference |
---|---|---|
"Luteolin is a naturally occurring flavonoid with diverse pharmacological properties such as anti-inflammatory, antioxidant and anticancer." | 5.46 | Effects of luteolin and luteolin-morphine co-administration on acute and chronic pain and sciatic nerve ligated-induced neuropathy in mice. ( Abdollahzadeh, M; Golmakani, E; Hashemzaei, M; Iranshahi, M; Rezaee, R; Tabrizian, K, 2017) |
"Ambroxol's effects were compared with those of gabapentin." | 5.33 | Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. ( Arndt, K; Gaida, W; Klinder, K; Weiser, T, 2005) |
"The degree of allodynia was most marked following 10 min of irradiation." | 5.32 | Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice. ( Berge, OG; Brodin, E; Flood, K; Gustafsson, H; Olgart, L; Stiller, CO, 2003) |
"Luteolin is a naturally occurring flavonoid with diverse pharmacological properties such as anti-inflammatory, antioxidant and anticancer." | 1.46 | Effects of luteolin and luteolin-morphine co-administration on acute and chronic pain and sciatic nerve ligated-induced neuropathy in mice. ( Abdollahzadeh, M; Golmakani, E; Hashemzaei, M; Iranshahi, M; Rezaee, R; Tabrizian, K, 2017) |
"Ambroxol's effects were compared with those of gabapentin." | 1.33 | Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. ( Arndt, K; Gaida, W; Klinder, K; Weiser, T, 2005) |
"The degree of allodynia was most marked following 10 min of irradiation." | 1.32 | Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice. ( Berge, OG; Brodin, E; Flood, K; Gustafsson, H; Olgart, L; Stiller, CO, 2003) |
" Thus, studies on the prevention and management of chronic pain should focus on preemptive or long-term administration of NMDA receptor antagonists." | 1.32 | Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. ( Aliev, K; Belozertseva, IV; Bespalov, AY; Danysz, W; Malyshkin, AA; Medvedev, IO; Parsons, CG; Sevostianova, NY; Sukhotina, IA; Zvartau, EE, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (88.89) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasukurthi, R | 1 |
Brenner, MJ | 1 |
Moore, AM | 1 |
Moradzadeh, A | 1 |
Ray, WZ | 1 |
Santosa, KB | 1 |
Mackinnon, SE | 1 |
Hunter, DA | 1 |
Hashemzaei, M | 1 |
Abdollahzadeh, M | 1 |
Iranshahi, M | 1 |
Golmakani, E | 1 |
Rezaee, R | 1 |
Tabrizian, K | 1 |
Hayashi, T | 1 |
Miyata, M | 1 |
Nagata, T | 1 |
Izawa, Y | 1 |
Kawakami, Y | 1 |
Vissers, K | 1 |
Adriaensen, H | 1 |
De Coster, R | 1 |
De Deyne, C | 1 |
Meert, TF | 1 |
Gustafsson, H | 1 |
Flood, K | 1 |
Berge, OG | 1 |
Brodin, E | 1 |
Olgart, L | 1 |
Stiller, CO | 1 |
Medvedev, IO | 1 |
Malyshkin, AA | 1 |
Belozertseva, IV | 1 |
Sukhotina, IA | 1 |
Sevostianova, NY | 1 |
Aliev, K | 1 |
Zvartau, EE | 1 |
Parsons, CG | 1 |
Danysz, W | 1 |
Bespalov, AY | 1 |
Gaida, W | 1 |
Klinder, K | 1 |
Arndt, K | 1 |
Weiser, T | 1 |
Hizue, M | 1 |
Pang, CH | 1 |
Yokoyama, M | 1 |
Akada, Y | 1 |
Mori, R | 1 |
Kato, Y | 1 |
Yamasaki, F | 1 |
Mochizuki, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy[NCT05558878] | 80 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
9 other studies available for formaldehyde and Lesion of Sciatic Nerve
Article | Year |
---|---|
Transcardial perfusion versus immersion fixation for assessment of peripheral nerve regeneration.
Topics: Animals; Artifacts; Axons; Cardiac Surgical Procedures; Disease Models, Animal; Dissection; Fixative | 2009 |
Effects of luteolin and luteolin-morphine co-administration on acute and chronic pain and sciatic nerve ligated-induced neuropathy in mice.
Topics: Acute Disease; Analgesics; Animals; Chronic Pain; Disease Models, Animal; Drug Therapy, Combination; | 2017 |
Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways.
Topics: Affect; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Fluvoxamine; Formaldehy | 2009 |
A chronic-constriction injury of the sciatic nerve reduces bilaterally the responsiveness to formalin in rats: a behavioral and hormonal evaluation.
Topics: Adrenocorticotropic Hormone; Animals; Behavior, Animal; Cold Temperature; Corticosterone; Formaldehy | 2003 |
Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice.
Topics: Acetates; Amines; Analgesics; Animals; Behavior, Animal; Cyclohexanecarboxylic Acids; Disease Models | 2003 |
Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Topics: Animals; Chronic Disease; Dizocilpine Maleate; Electrophysiology; Excitatory Amino Acid Antagonists; | 2004 |
Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.
Topics: Ambroxol; Amines; Analgesics; Animals; Behavior, Animal; Constriction, Pathologic; Cyclohexanecarbox | 2005 |
Involvement of N-methyl-D-aspartate-type glutamate receptor epsilon1 and epsilon4 subunits in tonic inflammatory pain and neuropathic pain.
Topics: Animals; Formaldehyde; Inflammation; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Pain | 2005 |
Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Baclofen; Behavior, Animal; Disease Models, Anima | 2005 |